Microbot Medical (NASDAQ:MBOT) Price Target Raised to $9.00

Microbot Medical (NASDAQ:MBOT) had its price objective upped by HC Wainwright from $7.00 to $9.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock.

Microbot Medical Stock Performance

Shares of NASDAQ MBOT opened at $2.03 on Friday. The stock has a market cap of $41.09 million, a PE ratio of -2.54 and a beta of 1.46. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The business has a fifty day moving average of $1.31 and a two-hundred day moving average of $1.09.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.